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A food-drug interaction may be defined 
as the alteration of absorption, metabolism, 
elimination or effect of a drug by a food 
component.1
Now, a number of questions follow – how 
knowledgeable are healthcare professionals 
about this subject? How willing are they 
to provide the correct information to the 
patient by looking it up on a reference book 
or on the patient’s insert? Do they have the 
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necessary tools at hand? Do they have the 
time?  
Regardless of the response to these 
questions healthcare professionals are duty 
bound to provide this information in a 
correct manner to the patient and in failing 
to do so they might compromise patient 
care. Severe adverse reactions, therapeutic 
failures and fatalities have been reported 
following food-drug interactions.2
Foods – general
The first occasion for a food-drug 
interaction to occur is during the absorption 
phase of the drug. Most drugs are optimally 
absorbed in the small intestine and food 
ingestion can either reduce or increase the 
rate or extent of absorption.3,4 
With some drugs the presence of 
increased amounts of stomach acid results 
in the destruction of acid-labile drugs.3,5. In 
other cases food components such as calcium 
or iron may chelate some drugs reducing 
their absorption. Delayed absorption does 
not necessarily reduce the total overall 
exposure to the drugs and the area under the 
curve (AUC) may be equivalent regardless of 
how the drug is taken.5 On the other hand 
some medicines should be taken after meals 
since their bioavailability is enhanced by 
food.1 Table 1 summarizes some of these 
interactions.
Alcohol
The two main types of interactions, 
which can occur following concurrent 
alcohol and medicine ingestion, are (i) 
CNS depression and (ii) the flushing 
reaction.6  The effects of drugs that have 
CNS depressant activity are enhanced by 
consumption of alcohol, thus impairing 
driving ability and other skills.  This 
interaction involves drugs such as 
amphetamines, analgesics, antiepileptics, 
antihistamines, antipsychotics, appetite 
suppressants, benzodiazepines, isoniazid, 
lithium, maproteline, metoclopramide, 
mianserin, selective serotonin reuptake 
inhibitors (SSRIs) and tricyclic 
antidepressants.6 
The flushing reaction also known as a 
disulfiram reaction occurs between alcohol 
and some drugs, chemicals and certain 
fungi, and although unpleasant and possibly 
frightening it is rarely dangerous.5,6  This 
reaction is expected with disulfiram since 
it blocks the metabolism of alcohol and 
leads to an accumulation of acetaldehyde 
in the blood stream resulting in flushing, 
fullness of the face and neck, tachycardias, 
breathlessness, giddiness, hypotension, 
nausea and vomiting.5,6,7 The reaction can 
occur with 10 minutes of alcohol ingestion 
and may last several hours.7 Drugs reported 
to provoke a similar reaction include azole 
antifungals, cephalosporins, furazolidone, 
griseofulvin, metronidazole and topical 
tacrolimus and pimecrolimus.6
Alcohol should also be avoided in 
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In pharmacists’ daily practice, particularly when advising patients 
regarding their dosage regimen, they are often faced with the 
recurring question “do I need to take this after a meal?” Sometimes it 
makes one wonder whether this is a true concern or whether it is just 
an excuse to eat! The truth, however, is that interactions between food 
and medicines can have a significant influence on the adverse effect 
profiles of many drugs and on the therapeutic success of the drug 
being administered. 
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patients on concurrent hepatotoxic 
medications such as paracetamol, 
methotrexate, leflunamide, and phenytoin.6,8
Grapefruit and grapefruit juice
Grapefruit and grapefruit juice alter 
the pharmacokinetics of several drugs 
such as statins, calcium channel blockers, 
antibiotics and others. This was, as often 
is the case, discovered accidentally in a 
study investigating alcohol-drug interactions 
where grapefruit juice was utilised to mask 
the taste of the alcohol being studied.9 
The major mechanism in the induction of 
grapefruit-drug interactions seems to be 
the ability of grapefruit to inhibit intestinal 
CYP3A4, thus reducing ‘first-pass’ metabolism 
leaving a higher concentration of drug 
circulating in the body.2,5,9 The concern 
is that concomitant administration of a 
single serving of grapefruit or its products 
with certain drugs may cause toxic effects 
based on increased exposure.9 For those 
patients who are unwilling to terminate their 
consumption of this product, alternative 
drugs within the same class that exhibit a 
weak or no interaction should be prescribed. 
Table 2 summarizes the most significant 
drug-grapefruit interactions.
Cranberry juice
Cranberry juice has gained a lot of 
popularity in recent years because of 
claims that it reduces the risk of urinary 
tract infections10 and because of its 
antioxidant potential. However, the current 
recommendation of the CSM (Committee on 
Safety of Medicines)/MHRA (Medicines and 
Healthcare products Regulatory Agency) 
in the UK is that patients taking warfarin 
should limit or avoid completely drinking 
cranberry juice.2. This measure was taken 
following reports that the anticoagulant 
effects of warfarin were increased in patients 
drinking cranberry juice. One patient had 
a very marked increase and died from a 
haemorrhage while a further patient had 
a reduction in his INR (International 
Normalized Ratio).2,11
Milk and dairy products
The absorption of most tetracyclines is 
markedly reduced by milk and other dairy 
products. Reduction is reported at up to 
65%.5 Doxycyline and minocycline are less 
affected by this food group although a 
reduced absorption of 25-30% is reported.2  
Dairy products also reduce the bioavailability 
of ciprofloxacin and norfloxacin.5  As a 
consequence, it is usual to recommend that 
tetracyclines and quinolones are taken one 
hour before food or 2 hours after food to 
avoid an interaction with all forms of dairy 
calcium.2
In the case of strontium, the 
manufacturer remarks that food, milk and 
dairy products reduce the bioavailability 
of strontium by 60 to 70% when compared 
to bioavailability following administration 
3 hours after a meal. For this reason 
recommendations state that strontium 
should be taken at bedtime at least 2 hours 
after eating.2,12
Caffeine
Caffeine is a methylxanthine derivative 
that is contained in tea, coffee, chocolate, 
and beverages and in compound analgesic 
preparations. Caffeine is a proven ergogenic 
aid, increasing athletic performance, 
endurance, and mental chronometry even at 
very low doses.13 As a consequence of this 
it is likely that caffeine-containing products 
will reduce the efficacy of hypnotics and 
increase the risk of insomnia. Patients on 
antiarrythmics should also avoid excessive 
caffeine because of the risk of tachycardias. 
Theophylline, which is chemically related 
to caffeine and licensed for the prophylaxis 
and treatment of reversible bronchospasm 
associated with asthma and chronic 
obstructive pulmonary disease, is a xanthine-
derivative.  Thus the concurrent consumption 
of other xanthine-containing products is 
contraindicated.14 
Recommendation Drugs Reason
Take	with	a	high	fat	meals	 •	Griseofulvin	 Increased	absorption
	 •	Albendazole
With food		 •	Acitretin	 Food enhances bioavailability
	 •	Carbamazepine
	 •	Fenofirate
	 •	Isotretinoin
	 •	Itraconazole	capsules
	 •	Ketoconazole
	 •	Labetalol
	 •	Lopinavir
	 •	Mebendazole
	 •	Tamsulosin
	 •	Tenofovir
	 •	NSAIDs	+	Aspirin	 To	minimise	gastrointestinal
	 •	Co-amoxiclav	 adverse	effects
1	hour	before	food	 •	Azithromycin capsules Food reduces bioavailability  
or	2	hours	after	 •	Indinavir	 either	because	drugs	are
	 •	Itraconazole	solution	 acid-labile	or	via	the
	 •	Lansoprazole	 formation	of	complexes	 	
	 •	Penicillins	 with	the	drug
	 •	Quinolones
	 •	Saquinavir
	 •	Tetracyclines
30 minutes before food	 •	Didanosine
	 •	Perindopril
	 •	Rifampicin
	 •	Alendronate	 Specifically	30	minutes
	 •	Risedronate	 before	the	first	food
  of the day
2	hours	after	eating	 •	Strontium	 Reduced	bioavailability
Table 1. Before food, with food or after food?
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With high doses caffeine also reduced the 
seizure threshold and produced a significant 
reduction in the anticonvulsant effects of 
carbamazepine, phenobarbitone, phenytoin, 
and valproate in mice.15 This interaction was 
pharmacodynamic in nature since caffeine 
did not affect the plasma concentrations 
of these anti-epileptics. In case of newer 
antiepileptics, both acute and chronic 
caffeine decreased the protective potential 
of gabapentin and topiramate but not that 
of lamotrigine and tiagabine.17 Regardless 
of this however none of the manufacturing 
companies advise against the consumption 
of such products.16,17,18,19,20,21,22
It is advisable to avoid caffeine-
containing products with other stimulant 
products such as ginseng, guarana, 
pseudoephedrine and ephedra (available in 
some slimming preparations). Fatalities have 
been reported with concomitant ephedra and 
caffeine use.23
Protein
Protein content in the diet may cause 
fluctuations in the response of parkinsonian 
patients being treated with levodopa. This 
is thought to be due to a reduction in 
the efficacy of levodopa secondary to the 
action of the amino acid methionine and a 
reduction in the blood levels of levodopa 
as a result of the amino acid tryptophan.   
Spreading out the intake of proteins and 
restricting daily allowance of protein to 
800mg/kg body weight is reported to reduce 
this interaction.2
 
Tyramine – rich foods
Perhaps the most feared food-drug 
interaction is that between monoamine 
oxidase inhibitors (MAOIs) and the amino 
acid tyramine.2,5 Tyramine is indirectly 
sympathomimetic and when its metabolism 
is suppressed, as it is by MAOIs, it can cause 
a significant release of norepinephrine, 
resulting in markedly increased blood 
pressure, cardiac arrhythmias, hyperthermia 
and cerebral hemorrhage. Fatalities have 
been reported5. As little as 6mg of tyramine 
can raise the blood pressure and 10 to 25mg 
of tyramine would be expected to cause 
a serious hypertensive reaction. Tyramine 
is found in foods such as cheeses, salami, 
sausages, smoked meats, yeast extracts, 
pickled foods, chocolate and drinks such as 
beers and wine. Since the tyramine levels 
vary so much it is impossible to guess the 
amount of tyramine present in any food and 
drinks.2 
Table 2. Interactions with grapefruit and grapefruit products2,9
Interacting drug Expected effect of interaction Patient advice
(oral form only) 
Amiodarone Increased peak serum level by 84% It is prudent to suggest
 and increased AUC of amiodarone to patients that they avoid
 by 50%. grapefruit juice.
 Reduced effect of amiodarone on 
 the PR and QTc intervals.
Calcium Channel The significant increase in the The manufacturers of these
blockers bioavailability of felodipine may products contraindicate the
 alter their haemodynamic effects. intake of grapefruit and
 The bioavailability of nifedipine its products, although this
 and nimodipine is also increased interaction is most
 without altering the haemodynamic significant in patients
 effect. The bioavailability of amlodipine, receiving felodipine.
 diltiazem and verapamil is only 
 minimally affected although with 
 verapamil some ECG changes were seen.   
Carbamazepine Possible carbamazepine toxicity Grapefruit or grapefruit  
  juice should be avoided
  but if its consumption is  
  desirable, carbamazepine  
  levels should be monitored. 
Cyclosporin Trough and peak serum levels and 
 bioavailability of cyclosporin is increased. Concurrent use should be  
  avoided.
Pimozide Raised pimozide levels may lead to Concurrent use is
 potentially fatal torsades de pointes contraindicated.
 arrhythmias.
Sildenafil, Grapefruit juice can increase the area Avoid concurrent use of
Tadalafil and under curve (AUC) of sildenafil by 23%. grapefruit and grapefruit
Vardenafil Although this is unlikely to be clinically juice.
 significant this combination is best
 avoided because concurrent use results
 in an increased variability in sildenafil 
 pharmacokinetics. Products within the 
 same class are likely to interact similarly.  
Simvastatin and Plasma levels of lovastatin and simvastatin Even small quantities of
Lovastatin can increase by upto 12-fold and 9-fold grapefruit and its products
 respectively if given with grapefruit juice, can cause a signification
 increasing the risk of muscle damage and interaction and thus
 possible development of rhabdomyolysis. concomitant use should 
  be avoided. 
Sirolimus Grapefruit juice may raise sirolimus Although the extent of this
 serum levels. interaction is unknown the 
  manufacturer suggest 
  avoidance of this product. 
Tacrolimus Grapefruit juice can markedly Combination should be
 increase serum levels of tacrolimus by avoided if consumption is
 up to 400% desirable close monitoring 
  is recommended. 
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A milder form of this reaction has also 
been observed with moclobemide, selegiline 
and large quantities of tyramine rich foods 
(e.g. 300g Gorgonzola® cheese).2 
Others
The effects of warfarin can be 
antagonized by vitamin K, which is found 
in large amounts in green vegetables such 
as spinach, broccoli, cabbage and green 
tea. Patients should be advised to avoid 
dramatic dietary alterations. Care should also 
be given to patients starting new vitamin 
Multiple choice questions
1. Patients on oral hypoglycaemics should avoid excessive 
amounts of:   
 a. Protein rich foods
 b. Alcohol
 c. Vegetables
 d. Black coffee with artificial sweeteners
2. Drugs which are acid-labile like penicillin have their 
efficacy reduced by:  
 a. Water
 b. Orange juice
 c. Black Coffee
 d. Alcohol
3. Iron supplements has its absorption reduced by: 
 a. Tea 
 b. Water 
 c. Orange Juice
 d. Black coffee 
4. Patients on ACE inhibitors should avoid large amounts of 
salt-substitutes avoid the risk of:  
 a. Constipation 
 b. Hypotension  
 c. Hypertensive Crisis  
 d. Hyperkalaemia 
5. How long after finishing a course of metronidazole 
should a person wait before he or she can drink alcohol? 
 a. 12 hours
 b. 24 hours
 c. 48 hours
 d. 1 week
6. Excessive consumptions of alcohol may increase the risk 
of gastrointestinal haemorrhage in patients taking:  
 a. NSAIDs
 b. Opioid analgesics
 c. Benzodiazepines
 d. Ginseng 
7. Alcohol may cause facial flushing or skin erythema in 
patients using:
 a. Topical corticosteroids
 b. Topical NSAIDs
 c. Topical antihistamines
 d. Topical tacrolimus 
8. When taken with grapefruit juice the following drug can 
cause severe rhabdomyolysis:
 a. Simvastatin
 b. Fluvastatin
 c. Atorvastatin
 d. Rosuvastatin  
9. High doses of omega-3 marine triglycerides 
 (4 capsules) increase bleeding time in patients on:
 a. Aspirin
 b. Warfarin
 c. Ticlopidine
 d. Clopidogrel  
10. Food reduces the absorption of: 
 a. Isotretinoin 
 b. Azithromycin suspension
 c. Azithromycin capsules
 d. Ketoconazole
A correct response of 80% and over will entitle MCPP members to 1 credit towards their annual continuous education requirement. 
Answers may be sent by email to: president@mcppnet.org by 30 September 2009.
supplements.2 Other foods such as garlic, 
mango, avocado, soybean products and 
herbs are know to interact with warfarin 
and patients should be referred to their 
anticoagulant book for more information.2,4,23
Conclusion
This review has highlighted the outcome 
of some common food-drug interactions. 
Needless to say it is quite impossible for 
a pharmacist to remember all the known 
clinically important reactions, which is why 
there are suitable reference publications 
to refer to such as the British National 
Formulary, Stockley’s Drug Interactions and 
specific product characteristics available on 
www.medicines.org.uk. 
Pharmacists should not fear opening a 
book or a package insert in front of a patient 
in order to guide them accordingly. Priority 
should be given to patients on drugs, which 
have a narrow therapeutic index, such as 
warfarin, and to elderly patients who are 
most at risk due to polypharmacy, renal and 
hepatic impairment.  
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Practice points
•	 It	is	the	duty	of	healthcare	professionals	to	educate	patients	on	the	possibility	of	
interactions between their medications and their diet. 
•	 Patients	require	correct	administration	instructions	so	as	to	get	the	maximum	benefit	
from their medicinal treatment and to avoid adverse reactions.
•	 Patients	should	be	given	clear	information	on	the	consequences	of	an	alcohol-drug	
interaction as this can prevent severe outcomes. 
•	 Patients	buying	vitamins	and	herbal	medicines	should	always	be	asked	for	a	medication	
history.
•	 If	one	knows	that	a	patient	is	unlikely	to	stick	to	the	dietary	advice	recommended	
with his/her medication than it would be advisable for the pharmacist to suggest an 
alternative. 
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